CFRXQ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CFRXQ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
ContraFect's tax expense for the months ended in Sep. 2023 was $0.00 Mil. Its tax expense for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00 Mil.
The historical data trend for ContraFect's Tax Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ContraFect Annual Data | |||||||||||||||||||||
Trend | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | |||||||||||
Tax Expense | Get a 7-Day Free Trial | - | - | - | - | - |
ContraFect Quarterly Data | ||||||||||||||||||||
Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | |
Tax Expense | Get a 7-Day Free Trial | - | - | - | - | - |
Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.
Tax Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ContraFect (OTCPK:CFRXQ) Tax Expense Explanation
In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.
Thank you for viewing the detailed overview of ContraFect's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.
Jane F Barlow | director | 6800 BROKEN SOUND PARKWAY NW, 3RD FLOOR, BOCA RATON FL 33487 |
Lishan Aklog | director | 420 LEXINGTON AVENUE, SUITE 300, NEW YORK NY 10171 |
Michael Messinger | officer: VP Finance | 238 PENNINGTON HARBURTON ROAD, PENNINGTON NJ 08534 |
Cary Sucoff | director | 1612 EAST CAPE CORAL PKWY, C/O LEGACY EDUCATION ALLIANCE, INC., CAPE CORAL FL 33904 |
David N. Low | director | EMBARCADERO FOUR, SUITE 650, SAN FRANCISCO CA 94111 |
Sol J Barer | director | C/O INSPIREMD, INC., 321 COLUMBUS AVENUE, BOSTON MA 02116 |
Lisa Ricciardi | director | C/O COGNITION THERAPEUTICS, INC, 2500 WESTCHESTER AVENUE, PURCHASE NY 10577 |
Joshua B Muntner | officer: SVP Business Development | 30 FIFTH AVENUE, 12F, NEW YORK NY 10011 |
Shanghai Fosun Pharmaceutical (group) Co., Ltd. | 10 percent owner | BUILDING A, NO. 1289 YISHAN ROAD, SHANGHAI F4 200233 |
Fosun Industrial Co., Ltd | 10 percent owner | FLAT/ROOM 808, ICBC TOWER, 3 GARDEN ROAD, HONG KONG F4 00000 |
Cara M Cassino | officer: Chief Medical Officer | 757 STONY POINT ROAD, BENSON VT 05743 |
Natalie Bogdanos | officer: General Counsel | 207-23 DARREN DRIVE, BAYSIDE NY 11360 |
Roger Pomerantz | director | 711 HARVEST HILL ROAD, CHALFONT PA 18914 |
Michael J. Otto | director | 303A COLLEGE ROAD EAST, PRINCETON NJ 08540 |
Steven C Gilman | director | 110 HARTWELL AVENUE, LEXINGTON MA 02421 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 06-25-2022
By GuruFocusNews GuruFocusNews • 07-09-2022
By Marketwired • 09-18-2023
By GuruFocusNews GuruFocusNews • 06-24-2022
By Marketwired • 06-27-2023
By sperokesalga sperokesalga • 04-26-2023
By Marketwired • 10-16-2023
By GuruFocusNews GuruFocusNews • 06-26-2022
By GuruFocusNews GuruFocusNews • 07-04-2022
By GuruFocusNews GuruFocusNews • 06-29-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.